Insider Trading activities at Avalo Therapeutics, Inc. (AVTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avalo Therapeutics, Inc. (AVTX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avalo Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1534120.

Total stock buying since 2015: $43,287,426.
Total stock sales since 2015: $2,174,948.
Total stock option exercises since 2015: $4,064.


 1   2 
23 insiders reported insider trading activities at Avalo Therapeutics, Inc. (AVTX):
Insider trading activities of Miller Joseph M
Insider trading activities of Marcus Ronald
Insider trading activities of Goldman Jonathan
Insider trading activities of Kaplan Gilla
Insider trading activities of Jones Randal
Insider trading activities of Moscato Robert Jr.
Insider trading activities of Greenleaf Peter
Insider trading activities of Cola Michael F
Insider trading activities of Pedder Simon
Insider trading activities of Greenway Schond L.
Insider trading activities of Boyd Steven
Insider trading activities of Truex Samantha
Insider trading activities of Chan Mitchell
Insider trading activities of Kantoff Aaron
Insider trading activities of Almenoff June Sherie
Insider trading activities of Hacksell Uli
Insider trading activities of Phillips Matthew V
Insider trading activities of Neil Garry Arthur
Insider trading activities of Caissa Capital Management Ltd.
Insider trading activities of Calias Pericles
Insider trading activities of Sullivan Christopher Ryan
Insider trading activities of Harrell James Archie Jr
Insider trading activities of Wilkins H Jeffrey

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Avalo Therapeutics, Inc. (AVTX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 0 $0 108,069 $0
2024 1,000 $12,749 0 $0 0 $0
2023 2,274,149 $1,676,196 3,683,542 $2,169,894 0 $0
2022 2,576,000 $2,209,604 0 $0 0 $0
2021 8,418,609 $16,386,487 0 $0 0 $0
2020 5,764,190 $9,717,089 0 $0 0 $0
2019 3,186,392 $8,029,043 0 $0 0 $0
2018 2,095,952 $2,711,115 1,270 $5,054 1,270 $4,064
2017 4,714,561 $2,534,443 0 $0 0 $0
2016 10,000 $10,700 0 $0 0 $0
2015 30,617 $0 0 $0 0 $0

Table 2. Monthly summary of insider trading at Avalo Therapeutics, Inc. (AVTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-03 0 $0 0 $0 108,069 $0
2024-11 1,000 $12,749 0 $0 0 $0
2023-06 1,651,996 $1,183,396 3,683,542 $2,169,894 0 $0
2023-05 65,824 $200,340 0 $0 0 $0
2023-04 106,329 $292,460 0 $0 0 $0
2023-02 450,000 $0 0 $0 0 $0
2022-03 736,000 $496,001 0 $0 0 $0
2022-02 428,000 $343,410 0 $0 0 $0
2022-01 1,412,000 $1,370,193 0 $0 0 $0
2021-12 14,917 $23,418 0 $0 0 $0
2021-09 5,700,000 $12,557,917 0 $0 0 $0
2021-08 200,000 $546,735 0 $0 0 $0
2021-06 3,692 $8,417 0 $0 0 $0
2021-01 2,500,000 $3,250,000 0 $0 0 $0
2020-12 28,865 $44,593 0 $0 0 $0
2020-11 100,000 $118,433 0 $0 0 $0
2020-09 100,000 $110,000 0 $0 0 $0
2020-06 2,170,630 $3,750,651 0 $0 0 $0
2020-04 4,280 $9,244 0 $0 0 $0
2020-03 2,104,133 $2,351,252 0 $0 0 $0
2020-02 1,256,282 $3,332,916 0 $0 0 $0
2019-12 8,575 $24,421 0 $0 0 $0
2019-09 2,200,000 $5,231,000 0 $0 0 $0
2019-08 360,682 $1,173,447 0 $0 0 $0

Table 3. Detailed insider trading at Avalo Therapeutics, Inc. (AVTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-03-28 Truex Samantha (Director) Option Ex 3,167 .00 0
2025-03-28 Goldman Jonathan (Director) Option Ex 3,167 .00 0
2025-03-28 Kantoff Aaron (Director) Option Ex 3,167 .00 0
2025-03-28 Sullivan Christopher Ryan (Chief Financial Officer) Option Ex 24,200 .00 0
2025-03-28 Chan Mitchell (Director) Option Ex 3,167 .00 0
2025-03-28 Neil Garry Arthur (Chief Executive Officer) Option Ex 64,867 .00 0
2025-03-28 Almenoff June Sherie (Director) Option Ex 3,167 .00 0
2025-03-28 Kaplan Gilla (Director) Option Ex 3,167 .00 0
2024-11-13 Almenoff June Sherie (Director) Buy 500 13.00 6,500
2024-11-12 Almenoff June Sherie (Director) Buy 500 12.50 6,249
2023-06-27 Boyd Steven (10% Owner) Sale 937,404 .52 486,512
2023-06-26 Caissa Capital Management Ltd. (10% Owner) Buy 1,608,000 .63 1,016,256
2023-06-26 Boyd Steven (10% Owner) Sale 2,746,138 .61 1,683,382
2023-06-20 Caissa Capital Management Ltd. (10% Owner) Buy 2,000 4.14 8,288
2023-06-16 Caissa Capital Management Ltd. (10% Owner) Buy 3,000 3.90 11,715
2023-06-15 Caissa Capital Management Ltd. (10% Owner) Buy 3,160 3.68 11,641
2023-06-14 Caissa Capital Management Ltd. (10% Owner) Buy 6,000 3.48 20,874
2023-06-13 Caissa Capital Management Ltd. (10% Owner) Buy 8,750 3.82 33,442
2023-06-12 Caissa Capital Management Ltd. (10% Owner) Buy 2,149 4.33 9,315
2023-06-09 Caissa Capital Management Ltd. (10% Owner) Buy 5,044 4.14 20,897
2023-06-09 Sullivan Christopher Ryan (Chief Financial Officer) Buy 511 3.42 1,747
2023-06-09 Neil Garry Arthur (CEO and Chairman of the Board) Buy 4,000 3.42 13,680
2023-06-08 Caissa Capital Management Ltd. (10% Owner) Buy 6,398 3.93 25,124
2023-06-07 Caissa Capital Management Ltd. (10% Owner) Buy 2,984 3.49 10,417
2023-05-31 Caissa Capital Management Ltd. (10% Owner) Buy 1,688 2.87 4,844
2023-05-30 Caissa Capital Management Ltd. (10% Owner) Buy 671 2.87 1,923
2023-05-25 Caissa Capital Management Ltd. (10% Owner) Buy 2,000 2.77 5,540
2023-05-24 Caissa Capital Management Ltd. (10% Owner) Buy 9,000 2.98 26,865
2023-05-22 Caissa Capital Management Ltd. (10% Owner) Buy 7,000 3.34 23,359
2023-05-19 Caissa Capital Management Ltd. (10% Owner) Buy 6,500 3.52 22,854
2023-05-18 Caissa Capital Management Ltd. (10% Owner) Buy 13,121 3.29 43,168
2023-05-08 Caissa Capital Management Ltd. (10% Owner) Buy 5,000 2.62 13,110
2023-05-05 Caissa Capital Management Ltd. (10% Owner) Buy 5,000 2.88 14,375
2023-05-04 Caissa Capital Management Ltd. (10% Owner) Buy 15,000 2.79 41,880
2023-04-27 Caissa Capital Management Ltd. (10% Owner) Buy 1,504 2.96 4,451
2023-04-26 Caissa Capital Management Ltd. (10% Owner) Buy 425 2.97 1,262
2023-04-25 Caissa Capital Management Ltd. (10% Owner) Buy 5,571 3.00 16,707
2023-04-24 Caissa Capital Management Ltd. (10% Owner) Buy 12,500 3.06 38,275
2023-04-20 Caissa Capital Management Ltd. (10% Owner) Buy 5,000 3.08 15,390
2023-04-18 Caissa Capital Management Ltd. (10% Owner) Buy 10,000 2.94 29,440
2023-04-17 Caissa Capital Management Ltd. (10% Owner) Buy 15,000 2.96 44,430
2023-04-11 Caissa Capital Management Ltd. (10% Owner) Buy 25,000 2.84 71,075
2023-04-10 Caissa Capital Management Ltd. (10% Owner) Buy 31,329 2.28 71,430
2023-02-07 Boyd Steven (10% Owner) Buy 450,000 .00 0
2022-03-14 Boyd Steven (Director) Buy 100,000 .65 64,900
2022-03-11 Boyd Steven (Director) Buy 100,000 .69 68,800
2022-03-10 Boyd Steven (Director) Buy 26,000 .70 18,226
2022-03-07 Boyd Steven (Director) Buy 325,000 .66 213,200
2022-03-04 Boyd Steven (Director) Buy 135,000 .70 95,175
2022-03-03 Boyd Steven (Director) Buy 50,000 .71 35,700
2022-02-25 Boyd Steven (Director) Buy 40,000 .79 31,720
2022-02-24 Boyd Steven (Director) Buy 100,000 .80 80,100
2022-02-22 Boyd Steven (Director) Buy 83,000 .77 64,076
2022-02-18 Boyd Steven (Director) Buy 55,000 .82 45,265
2022-02-17 Boyd Steven (Director) Buy 150,000 .81 122,249
2022-01-20 Boyd Steven (Director) Buy 12,000 .85 10,212
2022-01-19 Boyd Steven (Director) Buy 93,700 .88 82,081
2022-01-18 Boyd Steven (Director) Buy 206,300 .88 182,162
2022-01-14 Boyd Steven (Director) Buy 85,000 .93 78,965
2022-01-13 Boyd Steven (Director) Buy 312,700 1.00 313,950
2022-01-12 Boyd Steven (Director) Buy 57,300 1.04 59,763
2022-01-11 Boyd Steven (Director) Buy 16,003 .96 15,346
2022-01-10 Boyd Steven (Director) Buy 491,097 .99 484,712
2022-01-07 Boyd Steven (Director) Buy 137,900 1.04 143,002
2021-12-10 Greenway Schond L. (CFO) Buy 2,231 1.57 3,502
2021-12-10 Sullivan Christopher Ryan (Chief Accounting Officer) Buy 955 1.57 1,499
2021-12-10 Wilkins H Jeffrey (Chief Medical Officer) Buy 6,371 1.57 10,002
2021-12-10 Harrell James Archie Jr (Chief Commercial Officer) Buy 1,093 1.57 1,716
2021-12-10 Neil Garry Arthur (Chief Scientific Officer) Buy 4,267 1.57 6,699
2021-09-17 Boyd Steven (Director) Buy 5,454,545 2.20 11,999,999
2021-09-16 Boyd Steven (Director) Buy 150,000 2.28 341,999
2021-09-15 Boyd Steven (Director) Buy 95,455 2.26 215,919
2021-08-18 Boyd Steven (Director) Buy 20,000 2.78 55,560
2021-08-16 Boyd Steven (Director) Buy 30,000 2.75 82,650
2021-08-06 Boyd Steven Buy 25,000 2.83 70,625
2021-08-05 Boyd Steven Buy 25,000 2.77 69,300
2021-08-04 Boyd Steven Buy 100,000 2.69 268,600
2021-06-10 Neil Garry Arthur (Chief Scientific Officer) Buy 3,692 2.28 8,417
2021-01-08 Boyd Steven Buy 2,500,000 1.30 3,250,000
2020-12-10 Sullivan Christopher Ryan (Interim CFO) Buy 5,095 2.28 11,606
2020-12-10 Harrell James Archie Jr (Chief Commercial Officer) Buy 171 2.28 389
2020-12-10 Neil Garry Arthur (Chief Scientific Officer) Buy 3,599 2.28 8,198
2020-12-03 Boyd Steven Buy 20,000 1.22 24,400
2020-11-25 Boyd Steven Buy 15,000 1.20 17,925
2020-11-24 Boyd Steven Buy 47,733 1.20 57,279
2020-11-23 Boyd Steven Buy 37,267 1.16 43,229
2020-09-04 Boyd Steven Buy 100,000 1.10 110,000
2020-06-11 Boyd Steven Buy 28,000 2.44 68,320
2020-06-10 Sullivan Christopher Ryan (Interim CFO) Buy 2,954 2.28 6,729
2020-06-10 Harrell James Archie Jr (Chief Commercial Officer) Buy 6,391 2.28 14,558
2020-06-10 Neil Garry Arthur (Chief Scientific Officer) Buy 1,799 2.28 4,098
2020-06-09 Harrell James Archie Jr (Chief Commercial Officer) Buy 10,000 2.50 25,000
2020-06-09 Boyd Steven Buy 2,021,486 1.67 3,381,946
2020-06-09 Cola Michael F (Chief Executive Officer) Buy 100,000 2.50 250,000
2020-04-03 Boyd Steven Buy 4,280 2.16 9,244
2020-03-31 Boyd Steven Buy 26,611 2.33 62,003
2020-03-30 Boyd Steven Buy 49,303 2.35 115,862
2020-03-27 Boyd Steven Buy 36,000 2.43 87,480
2020-03-23 Boyd Steven Buy 1,374 2.52 3,462
2020-03-20 Boyd Steven Buy 9,626 2.50 24,065
2020-03-19 Boyd Steven Buy 1,567 2.60 4,074
2020-03-18 Boyd Steven Buy 28,433 1.91 54,307
2020-03-17 Boyd Steven Buy 1,951,219 1.02 1,999,999
2020-02-03 Boyd Steven Buy 1,256,282 2.65 3,332,916
2019-12-10 Miller Joseph M (Chief Financial Officer) Buy 2,598 2.85 7,399
2019-12-10 Calias Pericles (Chief Scientific Officer) Buy 2,913 2.85 8,296
2019-12-10 Harrell James Archie Jr (Chief Commercial Officer) Buy 3,064 2.85 8,726
2019-09-06 Boyd Steven Buy 1,000,000 1.48 1,475,000
2019-09-04 Boyd Steven Buy 1,200,000 3.13 3,756,000
2019-08-30 Boyd Steven Buy 24,591 3.23 79,428
2019-08-29 Boyd Steven Buy 17,173 3.21 55,125
2019-08-27 Pedder Simon (Executive Chairman of the Bd) Buy 6,734 2.98 20,100
2019-08-19 Boyd Steven Buy 2,298 1.78 4,097
2019-08-16 Boyd Steven Buy 9,886 1.72 16,954
2019-08-14 Boyd Steven Buy 113,684 3.37 383,114
2019-08-13 Boyd Steven Buy 58,376 3.30 192,640
2019-08-12 Boyd Steven Buy 27,940 3.20 89,408
2019-06-10 Miller Joseph M (Chief Financial Officer) Buy 1,179 2.85 3,357
2019-06-10 Calias Pericles (Chief Scientific Officer) Buy 4,549 2.85 12,955
2019-06-10 Harrell James Archie Jr (Exec. VP, Mktg & External Comm) Buy 4,398 2.85 12,525
2019-06-10 Phillips Matthew V (Chief Commercial Officer) Buy 523 2.85 1,489
2019-06-07 Boyd Steven Buy 10,000 4.88 48,750
2019-06-05 Boyd Steven Buy 5,000 2.48 12,425
2019-06-03 Boyd Steven Buy 10,000 2.37 23,650
2019-05-31 Boyd Steven Buy 13,800 2.46 33,879
2019-05-30 Boyd Steven Buy 18,200 2.32 42,224
2019-05-29 Boyd Steven Buy 19,000 2.31 43,985
2019-05-28 Boyd Steven Buy 3,500 2.46 8,610
2019-05-24 Boyd Steven Buy 11,400 2.50 28,557
2019-05-23 Boyd Steven Buy 14,100 2.52 35,602
2019-05-17 Boyd Steven Buy 1,798 2.67 4,791
2019-05-16 Boyd Steven Buy 8,202 2.58 21,120
2019-05-14 Boyd Steven Buy 4,909 2.63 12,935
2019-05-14 Pedder Simon (Executive Chairman of the Bd) Buy 6,000 5.06 30,336
2019-05-13 Boyd Steven Buy 12,587 2.42 30,523
2019-05-10 Boyd Steven Buy 2,504 2.48 6,197
2019-03-27 Boyd Steven Buy 10,000 2.74 27,400
2019-03-26 Boyd Steven Buy 26,238 3.67 96,214
2019-03-25 Boyd Steven Buy 13,762 2.70 37,157
2019-03-08 Boyd Steven Buy 4,000 1.82 7,280
2019-03-07 Boyd Steven Buy 6,000 1.81 10,884
2019-03-06 Boyd Steven Buy 364,486 2.36 859,093
2019-01-11 Boyd Steven Buy 12,651 3.90 49,300
2019-01-10 Boyd Steven Buy 800 3.70 2,958
2019-01-09 Boyd Steven Buy 545 3.79 2,064
2019-01-08 Boyd Steven Buy 500 3.70 1,849
2019-01-07 Boyd Steven Buy 6,504 3.65 23,746
2019-01-04 Boyd Steven Buy 20,000 3.42 68,320
2018-12-31 Boyd Steven Buy 12,300 1.06 13,025
2018-12-28 Boyd Steven Buy 26,499 1.04 27,558
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AVTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avalo Therapeutics, Inc. (symbol AVTX, CIK number 1534120) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.